Monoclonal Antibody Against N Terminal 439-451 Epitopes of Anti-Mullerian Hormone and Its Properties
Abstract
To prepare the specific monoclonal antibody against the N-terminal specific epitope peptide of anti-mullerian hormone (AMH) and to identify its specificity. Methods Using bioinformatics analysis software to predict the specific peptide fragment of AMH. Then synthesized four antigenic epitope peptide segments of mature N-terminal region of AMH as the screening target antigen. Synthesized AMH wholegene.Using the prokaryotic expression system to abtain recombinant AMH protein. Immunized BALB/c mice with the recombinant AMH, and prepared mouse spleen cells for fusing with SP/20 cells. Preparation of AMH monoclonal antibody by hybridoma technology. The monoclonal antibodies against AMH were screened by using four N-terminal epitope peptides (1: 439-451 RGRDPRGPGRAQ, 2: 273-285 PPRPSAELEESPP, 3: 42-54 DLDWPPGSPQEPL, 4: 494-506 WPQSDRNPRYGNH) as antigens, and indirect ELISA and Western blot were used to identify the antigen binding characteristics of the selected monoclonal antibodies. Results Two hybridoma cell lines with stable anti-AMH-1 and anti-AMH-2 antibody activities were screened. The two antibodies were named anti-AMH-1 and anti-AMH-2 respectively. The antibody titers were 1∶12 000 and 1∶1 600 after purification. Western blot confirmed that the two McAbs recognized different antigens. Anti-AMH-1 could not only recognize the N-terminal 439-451 epitope peptide of AMH, but also recognize the amino acid sequence of recombinant AMH, as well as the ovarian tissue. Anti-AMH-2 could recognize recombinant AMH and ovarian tissue. Conclusion Two monoclonal antibodies against N-terminal specific epitopes of human AMH were successfully constructed.
Keywords: Anti-mullerian hormone, Monoclonal antibodies, Features
Full Text:
PDFReferences
IWASE A， NAKAMURA T， OSUKA S， et al. Anti-Müllerian hormone as a marker of ovarian reserve: what have we learned, and what should we know? Reprod Med Biol，2016，15(3): 127–136.
MATHILDE V， JULIE L， FABIEN K， et al. Anti Müllerian hormone: more than a biomarker of female reproductive function. J Gynecol Obstet Hum Reprod，2019，48(1): 19–24.
HUANG C C， ORVIS G D， KWAN K M， et al. Lhx1 is required in Müllerian duct epithelium for uterine development. Dev Biol，2014， 389(2): 124–136.
AZIZI E， NAJI M， NAZARI L， et al. Serum anti-Müllerian hormone is associated with oocyte dysmorphisms and ICSI outcomes. Int J Gynaecol Obstet，2019，147(2): 179–186.
DEWAILLY D， LAVEN J. AMH as the primary marker for fertility. Eur J Endocrinol，2019，181(6): 45–51.
SONIGO C， BEAU I， BINART N， et al. Anti-Müllerian hormone in fertility preservation: clinical and therapeutic applications. Clin Med Insights Reprod Health， 2019， 13: 1179558119854755[2019-06-14]. https://doi.org/10.1177/1179558119854755.
BROER S L， BROEKMANS F J， LAVEN J S， et al. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update，2014，20(5): 688–701.
ZAROFF S， TAN G. Hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications. Bio Techniques， 2019，67(3): 90–93.
RANDOLPH J F， HARLOW S D， HELMUTH M E， et al. Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle. Hum Reprod，2014，29(3): 592–600.
LEVI M， HASKY N， STEMMER S M， et al. Anti-Müllerian hormone is a marker for chemotherapy-induced testicular toxicity. Endocrinology， 2015，156(10): 3818–3827.
MANCAUX A， GRARDEL CHAMBENOIT E， GAGNEUR O， et al. Granulosa cell tumor: difficulty of diagnosis and contribution of imaging. Gynecol Obstet Fertil，2013，41(7/8): 439–445.
GASSNER D， JUNG R. First fully automated immunoassay for anti-Müllerian hormone. Clin Chem Lab Med，2014，52(8): 1143–1152.
DEMIRDJIAN G， BORD S， LEJEUNE C， et al. Performance characteristics of the Access AMH assay for the quantitative determination of anti-Müllerian hormone (AMH) levels on the Access* family of automated immunoassay systems. Clin Biochem，2016， 49(16/17): 1267–1273.
Refbacks
- There are currently no refbacks.
